Sanofi’s Foundation S & Sobi extend partnership with the World Federation of Haemophilia Humanitarian Aid Programme: Paris Saturday, April 26, 2025, 09:00 Hrs [IST] Sanofi, thro ...

Transferring manufacturing of active pharmaceutical ingredients (API) to another listed company will allow Sanofi to focus on vaccines, rare diseases and oncology. According to Reuters Sanofi ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

Qure N.V. research and ratings by Barron's. View QURE revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.